Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:
Operating for a diverse roster of blue-chip clients, the ‘wonderfully thoughtful and methodical team’ at Pinsent Masons LLP is regarded as being at the forefront of the field of litigation, acting on a range of multi-jurisdictional litigation and multiplex transactional mandates. Steering the practice is Catherine Drew, who is considerably experienced in handling blockbuster medical products for multinational pharmaceutical companies. Charlotte Weekes fields a strong life sciences practice that encompasses SPC litigation and Christopher Sharp’s wide-ranging strengths include mandates arising from the sectors of life sciences, technology, medical devices and energy sectors. Mark Marfé principally focuses on technology patent litigation. James Marshall joined the practice from Taylor Wessing LLP in September 2023, bolstering the practice with his vast experience across the life sciences and telecoms sectors. Nicole Jadeja departed in December 2023, joining Bird & Bird LLP.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Wonderfully thoughtful and methodical team, seamlessly supportive of each other, engendering a great deal of confidence simply because of their manner in collaboration.’
‘Mark Marfé as the lead partner gives detailed, knowledgeable and actionable advice on complex issues. We can't recommend him highly enough.’
Kernmandanten
- Flynn Pharma
- Teva Pharmaceutical Industries
Highlight-Mandate
- Representing Accord before the UK Patents Court in the revocation of a patent concerning Ustekinumab.
- Acting for Accord & Sandoz in connection with ongoing litigation concerning a major prostate cancer drug, enzalutamide (Xtandi).